483
Amgen Manufacturing LtdAmgen Manufacturing Ltd – FDA 483, May 10, 2017
Record Details
Amgen Manufacturing Limited in Juncos, PR, was cited for deficiencies in its quality system during an inspection of its human drug manufacturing facility. The firm failed to adequately investigate product complaints for trends and causes, particularly for products like Enbrel and Repatha. Additionally, the annual product review for Enbrel did not include a required evaluation of complaints, despite distributed batches being within shelf life.
View Company Profile
ID · 90311ed7-7358-4c93-a318-71514a142128
Other documents for Amgen Manufacturing Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.